Brieflands
Journal finderSearch
·
Sign in

Journal of Advanced Immunopharmacology

e-ISSN 2950-5461
Home
Articles
    Current IssueArchiveIn PressAccepted ManuscriptsSearch
Instruction
About Journal
    Journal InformationBoards and EditorsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncement: New Journal TitleSupportContact Us
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Journal of Advanced Immunopharmacology
  6. /
  7. Articles
  8. /
  9. Monoclonal Antibodies (mAbs) Approved for Cancer Treatment in the 2020s
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

7 results·Updated September 23, 2026
← Back to article
1

Innovative methodology for flexible monitoring of various bioprocesses by using pre-existing Raman data coupled with automated transfer learning technique

Biotechnology Progress

May/June 2026

Schini A.

Open Access

2

Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells

Discover Oncology

December 2025

Kotemul K.

Open Access

3

Transcriptome Analysis Reveals the Induction of Apoptosis-Related Genes by a Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia

Antibodies

June 2024

Takheaw N.

Open Access

4

CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia

Exploration of Targeted Anti Tumor Therapy

2024

Kotemul K.

Open Access

5

Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery

Recent Advances in Drug Delivery and Formulation

2023

Kaliyaperumal R.

6

The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy

Journal of Cutaneous Pathology

January 2023

Seervai R.N.H.

7

Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect

Antibodies

December 2022

Tashima T.

Open Access

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.